OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
July 31, 2020
The company has begun development of a 3D bioreactor for the cGMP production of extracellular vesicle exosomes.
July 01, 2020
Identifying the source, assessing the risk, and removing residual impurities requires a strategic approach.
June 01, 2020
Advanced data analytics, including statistical modeling and machine learning technique, can enable more efficient and reliable bioprocesses.
May 20, 2020
This latest round of funding adds 14 new technology projects, workforce development, and Global Health Fund projects to NIIMBL's portfolio.
April 01, 2020
Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
The new patented process results in uniform, scalable production and the ability to deliver cell cargo similar to natural exosomes/extracellular vesicles.
March 02, 2020
Better understanding and control of cell behavior is yielding benefits, upstream and beyond.
February 01, 2020
The trend toward personalized medicines includes more complex manufacturing cycles that can benefit from advanced process modeling early on in the therapeutics’ development.
January 01, 2020
While cell and gene therapies differ in many ways, some of the best practices for process development and validation are similar.
December 01, 2019
Downstream process development and manufacturing play a crucial role to ensure safety, quality, identity, purity, and efficacy.